 | • レポートコード：D0GIR-02453 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、睡眠障害治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。睡眠障害治療の種類別市場規模（不眠症、過度睡眠、睡眠障害）、用途別市場規模（病院薬局、オンライン薬局、小売薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Sanofi、Neurim Pharmaceuticals、Somaxon Pharmaceuticals、Sunovion Pharmaceuticals、GSK、Takeda Pharmaceutical、Eli Lilly、Vanda Pharmaceuticals ・地域別グローバル市場分析 2015年-2020年 ・睡眠障害治療の北米市場（アメリカ、カナダ、メキシコ） ・睡眠障害治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・睡眠障害治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・睡眠障害治療の南米市場（ブラジル、アルゼンチン） ・睡眠障害治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：不眠症、過度睡眠、睡眠障害 ・用途別分析：病院薬局、オンライン薬局、小売薬局 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Sleep Disorder Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Sleep Disorder Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Sleep Disorder Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Sleep Disorder Therapeutics market has been segmented into:
Insomnia
Excessive Sleep
Disturbed Sleep
By Application, Sleep Disorder Therapeutics has been segmented into:
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Sleep Disorder Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Sleep Disorder Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Sleep Disorder Therapeutics market.
The report offers in-depth assessment of the growth and other aspects of the Sleep Disorder Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Sleep Disorder Therapeutics Market Share Analysis
Sleep Disorder Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Sleep Disorder Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Sleep Disorder Therapeutics sales, revenue and market share for each player covered in this report.
The major players covered in Sleep Disorder Therapeutics are:
Sanofi
Neurim Pharmaceuticals
Somaxon Pharmaceuticals
Sunovion Pharmaceuticals
GSK
Takeda Pharmaceutical
Eli Lilly
Vanda Pharmaceuticals
Table of Contents
1 Sleep Disorder Therapeutics Market Overview
1.1 Product Overview and Scope of Sleep Disorder Therapeutics
1.2 Classification of Sleep Disorder Therapeutics by Type
1.2.1 Global Sleep Disorder Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Sleep Disorder Therapeutics Revenue Market Share by Type in 2019
1.2.3 Insomnia
1.2.4 Excessive Sleep
1.2.5 Disturbed Sleep
1.3 Global Sleep Disorder Therapeutics Market by Application
1.3.1 Overview: Global Sleep Disorder Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Global Sleep Disorder Therapeutics Market by Regions
1.4.1 Global Sleep Disorder Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Sleep Disorder Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Sleep Disorder Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Sleep Disorder Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Sleep Disorder Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Sleep Disorder Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Sleep Disorder Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sanofi SWOT Analysis
2.1.4 Sanofi Product and Services
2.1.5 Sanofi Sleep Disorder Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Neurim Pharmaceuticals
2.2.1 Neurim Pharmaceuticals Details
2.2.2 Neurim Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Neurim Pharmaceuticals SWOT Analysis
2.2.4 Neurim Pharmaceuticals Product and Services
2.2.5 Neurim Pharmaceuticals Sleep Disorder Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Somaxon Pharmaceuticals
2.3.1 Somaxon Pharmaceuticals Details
2.3.2 Somaxon Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Somaxon Pharmaceuticals SWOT Analysis
2.3.4 Somaxon Pharmaceuticals Product and Services
2.3.5 Somaxon Pharmaceuticals Sleep Disorder Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sunovion Pharmaceuticals
2.4.1 Sunovion Pharmaceuticals Details
2.4.2 Sunovion Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Sunovion Pharmaceuticals SWOT Analysis
2.4.4 Sunovion Pharmaceuticals Product and Services
2.4.5 Sunovion Pharmaceuticals Sleep Disorder Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 GSK
2.5.1 GSK Details
2.5.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 GSK SWOT Analysis
2.5.4 GSK Product and Services
2.5.5 GSK Sleep Disorder Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Takeda Pharmaceutical
2.6.1 Takeda Pharmaceutical Details
2.6.2 Takeda Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Takeda Pharmaceutical SWOT Analysis
2.6.4 Takeda Pharmaceutical Product and Services
2.6.5 Takeda Pharmaceutical Sleep Disorder Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Eli Lilly
2.7.1 Eli Lilly Details
2.7.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Eli Lilly SWOT Analysis
2.7.4 Eli Lilly Product and Services
2.7.5 Eli Lilly Sleep Disorder Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Vanda Pharmaceuticals
2.8.1 Vanda Pharmaceuticals Details
2.8.2 Vanda Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Vanda Pharmaceuticals SWOT Analysis
2.8.4 Vanda Pharmaceuticals Product and Services
2.8.5 Vanda Pharmaceuticals Sleep Disorder Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Sleep Disorder Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Sleep Disorder Therapeutics Players Market Share
3.2.2 Top 10 Sleep Disorder Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Sleep Disorder Therapeutics Revenue and Market Share by Regions
4.2 North America Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Sleep Disorder Therapeutics Revenue by Countries
5.1 North America Sleep Disorder Therapeutics Revenue by Countries (2015-2020)
5.2 USA Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Sleep Disorder Therapeutics Revenue by Countries
6.1 Europe Sleep Disorder Therapeutics Revenue by Countries (2015-2020)
6.2 Germany Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Sleep Disorder Therapeutics Revenue by Countries
7.1 Asia-Pacific Sleep Disorder Therapeutics Revenue by Countries (2015-2020)
7.2 China Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Sleep Disorder Therapeutics Revenue by Countries
8.1 South America Sleep Disorder Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Sleep Disorder Therapeutics by Countries
9.1 Middle East & Africa Sleep Disorder Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Sleep Disorder Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Sleep Disorder Therapeutics Market Forecast by Type (2019-2024)
10.3 Insomnia Revenue Growth Rate (2015-2025)
10.4 Excessive Sleep Revenue Growth Rate (2015-2025)
10.5 Disturbed Sleep Revenue Growth Rate (2015-2025)
11 Global Sleep Disorder Therapeutics Market Segment by Application
11.1 Global Sleep Disorder Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Sleep Disorder Therapeutics Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2015-2020)
11.4 Online Pharmacies Revenue Growth (2015-2020)
11.5 Retail Pharmacies Revenue Growth (2015-2020)
12 Global Sleep Disorder Therapeutics Market Size Forecast (2021-2025)
12.1 Global Sleep Disorder Therapeutics Market Size Forecast (2021-2025)
12.2 Global Sleep Disorder Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America Sleep Disorder Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Sleep Disorder Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Sleep Disorder Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America Sleep Disorder Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Sleep Disorder Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Sleep Disorder Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Sleep Disorder Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Sleep Disorder Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Sleep Disorder Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Sanofi Corporate Information, Location and Competitors
Table 6. Sanofi Sleep Disorder Therapeutics Major Business
Table 7. Sanofi Sleep Disorder Therapeutics Total Revenue (USD Million) (2017-2018)
Table 8. Sanofi SWOT Analysis
Table 9. Sanofi Sleep Disorder Therapeutics Product and Solutions
Table 10. Sanofi Sleep Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Neurim Pharmaceuticals Corporate Information, Location and Competitors
Table 12. Neurim Pharmaceuticals Sleep Disorder Therapeutics Major Business
Table 13. Neurim Pharmaceuticals Sleep Disorder Therapeutics Total Revenue (USD Million) (2018-2019)
Table 14. Neurim Pharmaceuticals SWOT Analysis
Table 15. Neurim Pharmaceuticals Sleep Disorder Therapeutics Product and Solutions
Table 16. Neurim Pharmaceuticals Sleep Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Somaxon Pharmaceuticals Corporate Information, Location and Competitors
Table 18. Somaxon Pharmaceuticals Sleep Disorder Therapeutics Major Business
Table 19. Somaxon Pharmaceuticals Sleep Disorder Therapeutics Total Revenue (USD Million) (2017-2018)
Table 20. Somaxon Pharmaceuticals SWOT Analysis
Table 21. Somaxon Pharmaceuticals Sleep Disorder Therapeutics Product and Solutions
Table 22. Somaxon Pharmaceuticals Sleep Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Sunovion Pharmaceuticals Corporate Information, Location and Competitors
Table 24. Sunovion Pharmaceuticals Sleep Disorder Therapeutics Major Business
Table 25. Sunovion Pharmaceuticals Sleep Disorder Therapeutics Total Revenue (USD Million) (2017-2018)
Table 26. Sunovion Pharmaceuticals SWOT Analysis
Table 27. Sunovion Pharmaceuticals Sleep Disorder Therapeutics Product and Solutions
Table 28. Sunovion Pharmaceuticals Sleep Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. GSK Corporate Information, Location and Competitors
Table 30. GSK Sleep Disorder Therapeutics Major Business
Table 31. GSK Sleep Disorder Therapeutics Total Revenue (USD Million) (2017-2018)
Table 32. GSK SWOT Analysis
Table 33. GSK Sleep Disorder Therapeutics Product and Solutions
Table 34. GSK Sleep Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Takeda Pharmaceutical Corporate Information, Location and Competitors
Table 36. Takeda Pharmaceutical Sleep Disorder Therapeutics Major Business
Table 37. Takeda Pharmaceutical Sleep Disorder Therapeutics Total Revenue (USD Million) (2017-2018)
Table 38. Takeda Pharmaceutical SWOT Analysis
Table 39. Takeda Pharmaceutical Sleep Disorder Therapeutics Product and Solutions
Table 40. Takeda Pharmaceutical Sleep Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Eli Lilly Corporate Information, Location and Competitors
Table 42. Eli Lilly Sleep Disorder Therapeutics Major Business
Table 43. Eli Lilly Sleep Disorder Therapeutics Total Revenue (USD Million) (2017-2018)
Table 44. Eli Lilly SWOT Analysis
Table 45. Eli Lilly Sleep Disorder Therapeutics Product and Solutions
Table 46. Eli Lilly Sleep Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Vanda Pharmaceuticals Corporate Information, Location and Competitors
Table 48. Vanda Pharmaceuticals Sleep Disorder Therapeutics Major Business
Table 49. Vanda Pharmaceuticals Sleep Disorder Therapeutics Total Revenue (USD Million) (2017-2018)
Table 50. Vanda Pharmaceuticals SWOT Analysis
Table 51. Vanda Pharmaceuticals Sleep Disorder Therapeutics Product and Solutions
Table 52. Vanda Pharmaceuticals Sleep Disorder Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Global Sleep Disorder Therapeutics Revenue (Million USD) by Players (2015-2020)
Table 54. Global Sleep Disorder Therapeutics Revenue Share by Players (2015-2020)
Table 55. Global Sleep Disorder Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table 56. Global Sleep Disorder Therapeutics Revenue Market Share by Regions (2015-2020)
Table 57. North America Sleep Disorder Therapeutics Revenue by Countries (2015-2020)
Table 58. North America Sleep Disorder Therapeutics Revenue Market Share by Countries (2015-2020)
Table 59. Europe Sleep Disorder Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 60. Asia-Pacific Sleep Disorder Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 61. South America Sleep Disorder Therapeutics Revenue by Countries (2015-2020)
Table 62. South America Sleep Disorder Therapeutics Revenue Market Share by Countries (2015-2020)
Table 63. Middle East and Africa Sleep Disorder Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 64. Middle East and Africa Sleep Disorder Therapeutics Revenue Market Share by Countries (2015-2020)
Table 65. Global Sleep Disorder Therapeutics Revenue (Million USD) by Type (2015-2020)
Table 66. Global Sleep Disorder Therapeutics Revenue Share by Type (2015-2020)
Table 67. Global Sleep Disorder Therapeutics Revenue Forecast by Type (2021-2025)
Table 68. Global Sleep Disorder Therapeutics Revenue by Application (2015-2020)
Table 69. Global Sleep Disorder Therapeutics Revenue Share by Application (2015-2020)
Table 70. Global Sleep Disorder Therapeutics Revenue Forecast by Application (2021-2025)
Table 71. Global Sleep Disorder Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Sleep Disorder Therapeutics Picture
Figure 2. Global Sleep Disorder Therapeutics Revenue Market Share by Type in 2019
Figure 3. Insomnia Picture
Figure 4. Excessive Sleep Picture
Figure 5. Disturbed Sleep Picture
Figure 6. Sleep Disorder Therapeutics Revenue Market Share by Application in 2019
Figure 7. Hospital Pharmacies Picture
Figure 8. Online Pharmacies Picture
Figure 9. Retail Pharmacies Picture
Figure 10. Global Sleep Disorder Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Sleep Disorder Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Sleep Disorder Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Sleep Disorder Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Sleep Disorder Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Sleep Disorder Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Sleep Disorder Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Sleep Disorder Therapeutics Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Sleep Disorder Therapeutics Revenue Market Share in 2019
Figure 19. Global Top 10 Players Sleep Disorder Therapeutics Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Sleep Disorder Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Sleep Disorder Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 23. Global Sleep Disorder Therapeutics Revenue Market Share by Regions in 2018
Figure 24. North America Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 25. Europe Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 27. South America Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 29. North America Sleep Disorder Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 30. North America Sleep Disorder Therapeutics Revenue Market Share by Countries in 2019
Figure 31. USA Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 32. Canada Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 34. Europe Sleep Disorder Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Sleep Disorder Therapeutics Revenue Market Share by Countries in 2019
Figure 36. Germany Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 37. UK Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 38. France Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 39. Russia Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 40. Italy Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Sleep Disorder Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Sleep Disorder Therapeutics Revenue Market Share by Countries in 2019
Figure 43. China Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 44. Japan Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 45. Korea Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 46. India Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 48. South America Sleep Disorder Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 49. South America Sleep Disorder Therapeutics Revenue Market Share by Countries in 2019
Figure 50. Brazil Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Sleep Disorder Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Sleep Disorder Therapeutics Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 55. UAE Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Sleep Disorder Therapeutics Revenue and Growth Rate (2015-2020)
Figure 58. Global Sleep Disorder Therapeutics Revenue Share by Type (2015-2020)
Figure 59. Global Sleep Disorder Therapeutics Revenue Share by Type in 2019
Figure 60. Global Sleep Disorder Therapeutics Market Share Forecast by Type (2021-2025)
Figure 61. Global Insomnia Revenue Growth Rate (2015-2020)
Figure 62. Global Excessive Sleep Revenue Growth Rate (2015-2020)
Figure 63. Global Disturbed Sleep Revenue Growth Rate (2015-2020)
Figure 64. Global Sleep Disorder Therapeutics Revenue Share by Application (2015-2020)
Figure 65. Global Sleep Disorder Therapeutics Revenue Share by Application in 2019
Figure 66. Global Sleep Disorder Therapeutics Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospital Pharmacies Revenue Growth Rate (2015-2020)
Figure 68. Global Online Pharmacies Revenue Growth Rate (2015-2020)
Figure 69. Global Retail Pharmacies Revenue Growth Rate (2015-2020)
Figure 70. Global Sleep Disorder Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Sleep Disorder Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Sleep Disorder Therapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Sleep Disorder Therapeutics Revenue Market Forecast (2021-2025)
Figure 74. Europe Sleep Disorder Therapeutics Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Sleep Disorder Therapeutics Revenue Market Forecast (2021-2025)
Figure 76. South America Sleep Disorder Therapeutics Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Sleep Disorder Therapeutics Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
概日リズム睡眠障害の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Circadian Rhythm Sleep Disorder market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Circadian Rhy…- 双極性障害治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Bipolar Disorder Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.9% in the forecast period of 2020 to 2025 and will expected to reach USD 4283.5 million by 2025, from USD 3966.9 million in 2019. The Bipola…
- 睡眠検査サービスの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Sleep Testing Services market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.2% in the forecast period of 2020 to 2025 and will expected to reach USD 7952.4 million by 2025, from USD 6030.1 million in 2019. The Sleep Testing…
- 睡眠治療マシンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Sleep Therapy Machines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
- 睡眠追跡技術の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Sleep Tracking Technologies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Sleep Tracking Te…